|
| | |
|
Reinertsen was appointed CEO of CareGroup in 1998, in the hope that he could
implement cost cutting measures that would save the financially troubled
institution without adversely affecting patient care. In this excerpt from his
interview with FRONTLINE, he predicts that ultimately the health consumer has
to take greater financial responsibility for the rising costs of health
care.
| |
We have an interesting health care economy. I've described it, and many others
have described it, as a health care economy in which everybody will consume all
the care that somebody else will pay for. That's precisely the spot we've now
gotten ourselves into.
We've allowed it to run to the point where people are getting far more than
their employers and their government are, in fact, paying for. We need to
either provide a more limited form of treatment from the form of "everything we
always wanted," or we need to actually remove the waste from the system that is
currently there. My own preference is to assume that there's waste and to
remove it, rather than to assume that there is excess and ration it in some
way.
It's very easy to very quickly start blaming the consumer for this problem.
And that's not really where we should go. The truth is that the way in which
the services are being provided to the consumer causes the consumer to believe
that they are necessary and, therefore, they want those services. And the way
they are provided is also extremely inefficient. Also, it costs a tremendous
amount. The consumer wants the services, x-rays, pharmaceuticals,
hospitalizations, visits to doctors, and all of these things we do far more
today than we did 20 years ago. The exception is hospitalization--we don't go
into the hospital as much. But we visit the doctor more. We get far more
prescriptions per year than any population in history, and we pay very little
for those out of pocket or have any other recognition of what the costs
actually are.
So the demand is unchecked, the supply is inefficiently organized, and the
result is that it costs us a lot more to deliver them than we're getting paid
for. . . . .
Do you think it's a good idea for doctors to be thinking simultaneously
about care and about the cost of care?
I think it's important for doctors to know the value of the services they're
providing. That means they have to know both the quality of the care and the
cost of the care. Let me give you a specific example.
I used to take care of a lot of patients in a first-dollar coverage situation
in Minneapolis. . . . And they had no out-of-pocket costs for most care, and
maybe a five-dollar co-payment for any prescription. I developed a certain way
of taking care of them. After a few years, I started going out into the
country, a couple of hours away, to take care of patients and see them in a
small town one day a month. I did exactly the same sort of practice methods
that I did in the city. After I saw patients back on the return visits, though,
I began to learn something about the country insurance that I didn't understand
about the folks in the city. The farmers out there would have catastrophic
coverage, in which they would have a $5,000 deductible. After that, things
were covered. They bought insurance so they wouldn't lose the family farm.
When I'd come back to see them a month or two later, they'd say, "Doc, do you
know how much that pill you gave me costs?" And my bad answer was, "I don't
know, what did it cost, John?" And he'd say, "Sixty bucks." And then he would
ask a very important question: "Do you have something that would work just
about as well, but would cost less?" And it turns out I did, but I just hadn't
thought about it. He was paying out of pocket for this prescription, and I'd
never had any mindset at all about what things cost, because my patients didn't
have any mindset about it. It's very important in the doctor/patient
relationship for us to be in sync on this one. I can be a valued adviser for
my patients if they have concerns about the costs of the treatments or the
interventions or the diagnostic methods that are being used.
Your doctors consistently say they're most worried about the doctor/patient
relationship, that patients no longer trust me to give them the best care.
They think the doctor is worried about the bottom line.
We've had an interesting transition in the country from the old days. There
wasn't any insurance at all, and the doctor just took care of the patient in
return for whatever they could pay, in which case the doctor's interests
economically were, in an interesting way, not necessarily all aligned with the
patients. And then there was an era where third-party payors paid on an
indemnity basis for whatever the doctor and patient decided they want to go and
get. Then managed care came in and said, "No, you can't get these things,"
after the doctor ordered them. The second era of managed care put the risk on
to the doctor, so the doctor's pocketbook was now paying for the decisions.
And that's the point that you're describing where the distrust starts to get
into the room. We need to get past that phase of things, very quickly, and
many plans are doing this. We are working at ways of getting out of such
arrangements, where we, in effect, are aligning our interests with those of the
patient.
The real critical thing for patients to understand is that when they walk into
a room with a doctor and they sit down and the doctor's evaluating them, how
that doctor is paid is a very important thing for the patient to know. The very
best way for a doctor to be paid is on a salary, where whether the doctor makes
decisions to do something for the patient, a procedure, an x-ray or something,
or not to do something for the patient is totally irrelevant to the doctor's
income. The doctor is simply there to make the best judgment possible on behalf
of the patient. That is the very best method of payment. It's not silly or
unwise for the doctor to be aware of costs when doing that, because ultimately
the patient and the taxpayer literally pays for all of these costs one way or
another. But there's no personal income at stake. A firewall needs to be
drawn . . .
How do you get out of the situation where you're in now--that a lot of your
doctors say they're in now--where the financial incentives are on them to limit
treatment, particularly primary care physicians?
Probably the only way, ultimately, that we can get out of a situation where
physicians are put in this bad guy role of limiting treatment is to put the
patients back into a role of having a stake in the cost of the treatment. Then
the physician's and the patient's interests once again become aligned, like my
rural farmer. That farmer had a problem, and he knew that I could make
recommendations one way or the other. If I made a very costly recommendation,
I knew and he knew that he was paying the bill. And he might ask me to try a
different tack here, and see how it goes, and I could counsel on the
advisability of that. And I can tell you, very interestingly, I never ever
encountered wanting to do something expensive because I knew it was potentially
lifesaving or was really important, and had one of those people with
catastrophic insurance coverage in my farmer population ever say, "No, I'm not
going to do it, Doc, it costs too much." I never had trouble convincing them
about what the right thing was to do. They often reminded me about how
expensive my recommendations were, and I would often be able to find a less
expensive path for us to go in. That aligns those interests. I didn't lose
any trust with those patients. In fact, we had a better trusting relationship
than I had with first-dollar coverage HMO patients in my practice in
Minneapolis.
The only people making money in health care right now are the pharmaceutical
companies and the device manufacturers. They're able to sell their wares to an
intermediary, in this case to a hospital, who then delivers their products. If
it's a device, the hospital puts it into the body of a patient to help them get
better, or gives them the medications to cure their cancer. And then has to
go to try to collect the bill. We do treatments here that cost us $50,000 just
for the treatment in the hospital, for which the total payment from the federal
government and from the payors for the whole hospitalization is $11,000. And
we do those every day. We're probably doing several today, such as giving
chemotherapy like Interluken-2 for some advanced cancers. The people that are
making the drug are getting their investment repaid. We bought it from them.
It costs us $50,000, we're putting it into a patient, and getting paid $11,000
for it.
And when you're saying that the patient needs to be a co-payor, it's a fact
that people are complaining about paying higher health insurance premiums.
Employers are shifting more of the burden onto their employees to pay more of
the premium. We have 44 million people who have no insurance in this country
today. . . . We have over-insured 80 percent of the public, and that costs us
so much that we can't buy it for the rest of the 20 percent. By
over-insurance, I mean they have access to a lot of stuff that simply has
little or no value, and it is being done every day all over the place--x-rays,
knee arthroscopies, and procedures of one kind or another are being done all
over America today that have relatively little value, although they are
evidence of quality in the sense that they show that we're trying hard.
And the reason they are being done to the extent they are, and the reason that
they are priced as highly as they are, is because none of them have had to
stand the scrutiny of a patient market saying, "Wait a second, if I have to buy
that, I'm not paying $800 for this x-ray. I might pay $300 for it." I think
several things would happen if patients bore a greater portion of the costs for
certain kinds of interactions at the time they happen. One is that the price
would come down, because the market wouldn't sustain it. If patients judge
many things as having no value, the market would not sustain the prices. And
the second is the frequency with which they're done would dramatically
decrease. The total cost would go down so far, we could extend coverage to the
other 20 percent who now don't have it.
home ·
inside the dilemma ·
financial incentive ·
interviews ·
cost v. care
discussion ·
ask the producer ·
producer's notebook ·
links ·
tapes & transcripts ·
synopsis
|